Board members

Our Board Members bring diverse professional skills and personal dedication, unified by their passion for driving Cure OGT’s mission forward. Combining expertise from technology, finance, and entrepreneurship, they provide strategic oversight and practical guidance for organizational growth. Each member is personally invested in advancing research and treatment efforts for OGT-XLID.

Andrey Skripkin
Andrey Skripin

Board Member

Product professional and entrepreneur with over 15 years’ experience; father of a daughter with OGT-XLID.

Linkedin
Olga Ovcharenko
Olga Ovcharenko

Board Member

Financial professional with a decade of non-profit sector experience.

Linkedin
Sasha Timoshenko
Sasha Timoshenko

Board Member

Experienced IT professional.

Linkedin

Scientific Board

Our Scientific Board comprises internationally recognized researchers dedicated to understanding OGT-XLID. Each scientist brings extensive experience and an impressive track record in the fields of glycobiology, molecular biology, and cellular research. Their collaboration ensures that our approach to finding treatments is scientifically rigorous, evidence-based, and innovative.

Lance Wells
Lance Wells

University of Georgia

Linkedin
Daan Van Aalten 850x850
Daan van Aalten

Aarhus University

Linkedin
Stephanie Olivier-Van Stichelen, PhD
Stephanie Olivier-Van Stichelen

Medical College of Wisconsin

Linkedin
Natasha E. Zachara, PhD
Natasha Zachara

Johns Hopkins School of Medicine

Linkedin
Michael Boyce
Michael Boyce

Duke University Medical Center

Linkedin